Neu
Sale
SARS CoV-2 Spike Glycoprotein South Africa variant Positive Control for STJ506303 peptide (South Africa variant) (STJ506307); 5applications
Art.-Nr.: STJ506307-5
SARS CoV-2 Spike Glycoprotein South Africa variant Positive Control for STJ506303 peptide (South Africa variant) (STJ506307); 5applications
ab 1
555,00 €
+ 19,00% MwSt.